ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

603168

CNE100001TG0

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
8.25 ^CNY	+0.36%		+0.24%	-38.48%

Apr. 29	Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Announces Distribution for 2019, Payable on June 12, 2020

June 04, 2020

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced implemented the scheme of rights and interests distribution for 2019 as follows: a cash dividend of RMB 0.011 (taxes included) per A share. Record date is June 11, 2020, Ex-dividend date is June 12, 2020 an Cash dividend payable date is June 12, 2020.

Latest news about Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Shapuaisi Pharma Gets China's Nod to Market Sodium Hyaluronate Eye Drops	Apr. 17	MT
Shapuaisi Pharma Gets Marketing Authorization for Moxifloxacin Hydrochloride Eye Drops	Apr. 09	MT
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-13	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Shanghai Lechun Biotechnology Co., Ltd. sign a share transfer agreement to acquire a 14.5% stake in Advanced Sterile Solutions Biotechnology Co., Ltd. from Shanghai Changgeng Industrial Development Co., Ltd. and Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. for CNY 40.6 million.	23-06-08	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Taizhou Women and Children's Hospital Co., Ltd. announced that it expects to receive CNY 231.1828 million in funding from Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.	23-01-17	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. agreed to acquire Qingdao Shikang Eye Hospital Co., Ltd. from Shanghai Fangzhi Medical Management Co., Ltd. for CNY 66.5 million	23-01-03	CI
Zhejiang Shapuaisi Pharma Shareholder Boosts Stake Through $44 Million Deal	22-11-09	MT
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it has received CNY 317.999993 million in funding from Shanghai Yanghe Investment Management Co., Ltd. and other investor.	22-10-24	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it expects to receive funding from Shanghai Yanghe Industrial Co., Ltd.	22-09-23	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-28	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI
Shanghai Tonghui Medical Management Co., Ltd. completed the acquisition of 5.43% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. from Chen Dekang.	21-05-19	CI
Shanghai Tonghui Medical Management Co., Ltd. signed a share transfer agreement to acquire 5.43% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. from Chen Dekang for approximately CNY 400 million.	21-05-06	CI
Zhejiang Shapuaisi Pharma's Shareholder to Sell 5.4% Stake for 396.5 Mln Yuan	21-04-27	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-19	CI
Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. signed an agreement to acquire Shapuaisi Qiangshen Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. for CNY 82 million.	21-04-09	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 599.999995 million in funding from Shanghai Yanghe Investment Management Co., Ltd. and another investor	20-12-16	CI

Chart Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Duration

Period

Chart Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

More charts

Company Profile

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the production, research, development and sale of chemical medicine and Chinese patent drugs. The Company's chemical medicine products mainly include Shapuaisi Bendazac Lysine Eye Drops, infusion products and cefixime products. The Company's Chinese patent drugs include kidney tonifying and nerve soothing products, such as Sizi Tianjing Capsules and Compound Gaoshan Hongjingtian Solution. The Company distributes its products in domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.	-38.48%	430M
ELI LILLY AND COMPANY	+40.73%	734B
NOVO NORDISK A/S	+32.83%	591B
JOHNSON & JOHNSON	-6.30%	350B
MERCK & CO., INC.	+15.15%	315B
ABBVIE INC.	+4.05%	276B
ASTRAZENECA PLC	+15.00%	238B
NOVARTIS AG	+9.78%	206B
ROCHE HOLDING AG	-5.52%	204B
AMGEN INC.	+6.17%	161B

Other Pharmaceuticals